[Federal Register Volume 82, Number 130 (Monday, July 10, 2017)]
[Notices]
[Pages 31780-31781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14515]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Sunshine Act Meeting: Advisory Board on Radiation and Worker 
Health (ABRWH or Advisory Board), National Institute for Occupational 
Safety and Health (NIOSH)

Time/s/ and Date/s/: 

8:15 a.m.-5:30 p.m., Mountain Time, August 23, 2017
8:15 a.m.-4:30 p.m., Mountain Time, August 24, 2017


Public Comment Times and Dates: 5:30 p.m.-6:30 p.m., Mountain Time, 
August 23, 2017.

Place: Courtyard Marriott, 3347 Cerrillos Road, Santa Fe, New Mexico 
87507; Phone: (505) 473-2800 Fax: (505) 473-5128.

Status: In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee. This meeting is Open to the public, limited only by the 
space available. The meeting space accommodates approximately 100 
people. Audio Conference Call via FTS Conferencing. The USA toll-free, 
dial-in number is 1-866-659-0537 with a pass code of 9933701. Skype 
Meeting Connection: https://webconf.cdc.gov/zab6/yzdq02pl?sl=1

Matters to be Considered: The Advisory Board was established under the 
Energy Employees Occupational Illness Compensation Program Act of 2000 
to advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines which have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule, advice on methods of dose reconstruction which have 
also been

[[Page 31781]]

promulgated by HHS as a final rule, advice on the scientific validity 
and quality of dose estimation and reconstruction efforts being 
performed for purposes of the compensation program, and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, rechartered on March 22, 2016 
pursuant to Executive Order 13708, and will expire on September 30, 
2017.
    This Advisory Board is charged with (a) providing advice to the 
Secretary, HHS, on the development of guidelines under Executive Order 
13179; (b) providing advice to the Secretary, HHS, on the scientific 
validity and quality of dose reconstruction efforts performed for this 
program; and (c) upon request by the Secretary, HHS, advising the 
Secretary on whether there is a class of employees at any Department of 
Energy facility who were exposed to radiation but for whom it is not 
feasible to estimate their radiation dose, and on whether there is 
reasonable likelihood that such radiation doses may have endangered the 
health of members of this class.
    The agenda for the Advisory Board meeting includes: NIOSH Program 
Update; Department of Labor Program Update; Department of Energy 
Program Update; SEC Petitions Update; Site Profile reviews for Pantex 
Plant (Amarillo, Texas), Pacific Proving Grounds (Marshall Islands), 
Feed Materials Production Center (Fernald, Ohio), and possibly Nevada 
Test Site (Mercury, Nevada); SEC petitions for: Metals and Control 
Corp. (1968-1997; Attleboro, Massachusetts), Los Alamos National 
Laboratory (1996-2005; Los Alamos, New Mexico), Idaho National 
Laboratory (1970-1980; Scoville, Idaho), Area IV of Santa Susanna Field 
Laboratory (1991-1993; Ventura County, California), Savannah River Site 
(1973-2007; Aiken, South Carolina), and possibly either Ames Laboratory 
(1971-undetermined ending date; Ames, Iowa) or Grand Junction 
Facilities (1986-2010; Grand Junction, CO); and Board Work Sessions.
    The agenda is subject to change as priorities dictate. In the event 
an individual cannot attend, written comments may be submitted to the 
contact person below well in advance of the meeting. Any written 
comments received will be provided at the meeting in accordance with 
the redaction policy provided below.
    Policy on Redaction of Board Meeting Transcripts (Public Comment):
    (1) If a person making a comment gives his or her personal 
information, no attempt will be made to redact the name; however, NIOSH 
will redact other personally identifiable information, such as contact 
information, social security numbers, case numbers, etc., of the 
commenter.
    (2) If an individual in making a statement reveals personal 
information (e.g., medical or employment information) about themselves 
that information will not usually be redacted. The NIOSH Freedom of 
Information Act (FOIA) coordinator will, however, review such 
revelations in accordance with the Federal Advisory Committee Act and 
if deemed appropriate, will redact such information.
    (3) If a commenter reveals personal information concerning a living 
third party, that information will be reviewed by the NIOSH FOIA 
coordinator, and upon determination, if deemed appropriate, such 
information will be redacted, unless the disclosure is made by the 
third party's authorized representative under the Energy Employees 
Occupational Illness Compensation Program Act (EEOICPA) program.
    (4) In general, information concerning a deceased third party may 
be disclosed; however, such information will be redacted if (a) the 
disclosure is made by an individual other than the survivor claimant, a 
parent, spouse, or child, or the authorized representative of the 
deceased third party; (b) it is unclear whether the third party is 
living or deceased; or (c) the information is unrelated or irrelevant 
to the purpose of the disclosure. The Board will take reasonable steps 
to ensure that individuals making public comment are aware of the fact 
that their comments (including their name, if provided) will appear in 
a transcript of the meeting posted on a public Web site. Such 
reasonable steps include: (a) A statement read at the start of each 
public comment period stating that transcripts will be posted and names 
of speakers will not be redacted; (b) A printed copy of the statement 
mentioned in (a) above will be displayed on the table where individuals 
sign up to make public comments; (c) A statement such as outlined in 
(a) above will also appear with the agenda for a Board Meeting when it 
is posted on the NIOSH Web site; (d) A statement such as in (a) above 
will appear in the Federal Register Notice that announces Board and 
Subcommittee meetings.

Contact Person for More Information: Theodore Katz, Designated Federal 
Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta, Georgia 
30333, telephone: (513)533-6800, toll free: 1-800-CDC-INFO, email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-14515 Filed 7-6-17; 4:15 pm]
 BILLING CODE 4163-18-P